nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—KCNH2—purkinje fiber—dilated cardiomyopathy	0.564	0.591	CbGeAlD
Dimetindene—KCNH2—endocardium—dilated cardiomyopathy	0.29	0.305	CbGeAlD
Dimetindene—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.0244	0.0256	CbGeAlD
Dimetindene—KCNH2—myocardium—dilated cardiomyopathy	0.023	0.0241	CbGeAlD
Dimetindene—CHRM2—heart—dilated cardiomyopathy	0.0222	0.0233	CbGeAlD
Dimetindene—KCNH2—heart—dilated cardiomyopathy	0.016	0.0168	CbGeAlD
Dimetindene—Disopyramide—SCN5A—dilated cardiomyopathy	0.0158	0.395	CrCbGaD
Dimetindene—KCNH2—cardiac atrium—dilated cardiomyopathy	0.0137	0.0144	CbGeAlD
Dimetindene—Mepyramine—SLC22A5—dilated cardiomyopathy	0.0124	0.308	CrCbGaD
Dimetindene—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00741	0.185	CrCbGaD
Dimetindene—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00451	0.112	CrCbGaD
Dimetindene—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.000505	0.0796	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000306	0.0482	CbGpPWpGaD
Dimetindene—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000283	0.0447	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000218	0.0343	CbGpPWpGaD
Dimetindene—HRH1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000193	0.0304	CbGpPWpGaD
Dimetindene—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00019	0.0299	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000163	0.0256	CbGpPWpGaD
Dimetindene—HRH1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000162	0.0256	CbGpPWpGaD
Dimetindene—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00016	0.0252	CbGpPWpGaD
Dimetindene—HRH1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000156	0.0247	CbGpPWpGaD
Dimetindene—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000154	0.0243	CbGpPWpGaD
Dimetindene—HRH1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000131	0.0207	CbGpPWpGaD
Dimetindene—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000129	0.0204	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000124	0.0195	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00012	0.019	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000119	0.0187	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000117	0.0184	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000116	0.0183	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	9.85e-05	0.0155	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	9.7e-05	0.0153	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	9.06e-05	0.0143	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	8.87e-05	0.014	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	8.71e-05	0.0137	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	8.51e-05	0.0134	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	7.37e-05	0.0116	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	6.84e-05	0.0108	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	5.69e-05	0.00896	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	4.7e-05	0.0074	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	4.61e-05	0.00726	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.53e-05	0.00713	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	4.39e-05	0.00691	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	4.39e-05	0.00691	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	4.14e-05	0.00652	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	4.12e-05	0.00649	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	4.08e-05	0.00643	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	4.07e-05	0.00642	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.92e-05	0.00618	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.85e-05	0.00606	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.79e-05	0.00597	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.73e-05	0.00587	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	3.68e-05	0.0058	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.67e-05	0.00578	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	3.58e-05	0.00564	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.55e-05	0.00559	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.55e-05	0.00559	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.49e-05	0.0055	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.49e-05	0.0055	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.3e-05	0.00519	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.24e-05	0.00511	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	3.19e-05	0.00503	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.18e-05	0.00501	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	3.14e-05	0.00495	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.13e-05	0.00493	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	3.02e-05	0.00476	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.97e-05	0.00468	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	2.9e-05	0.00456	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.81e-05	0.00442	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.73e-05	0.0043	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.7e-05	0.00425	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.7e-05	0.00425	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	2.7e-05	0.00425	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.68e-05	0.00423	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.66e-05	0.00419	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.66e-05	0.00419	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	2.59e-05	0.00408	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.59e-05	0.00408	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.55e-05	0.00401	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.51e-05	0.00396	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.47e-05	0.00389	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.43e-05	0.00383	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.39e-05	0.00377	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	2.37e-05	0.00374	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	2.37e-05	0.00374	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.08e-05	0.00327	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.04e-05	0.00322	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.97e-05	0.0031	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.94e-05	0.00305	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.92e-05	0.00302	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.89e-05	0.00297	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	1.8e-05	0.00283	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	1.63e-05	0.00256	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.53e-05	0.0024	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.53e-05	0.0024	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.5e-05	0.00237	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.5e-05	0.00237	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.49e-05	0.00235	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.46e-05	0.0023	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.44e-05	0.00227	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.42e-05	0.00224	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.4e-05	0.0022	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.39e-05	0.00218	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.39e-05	0.00218	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.37e-05	0.00216	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.36e-05	0.00215	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.36e-05	0.00215	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.35e-05	0.00213	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.29e-05	0.00203	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.27e-05	0.002	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.25e-05	0.00197	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	1.23e-05	0.00194	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.23e-05	0.00193	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.17e-05	0.00185	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.15e-05	0.00182	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.11e-05	0.00175	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.1e-05	0.00173	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.07e-05	0.00168	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.05e-05	0.00165	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.01e-05	0.00159	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.95e-06	0.00157	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.22e-06	0.00145	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.07e-06	0.00143	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.64e-06	0.00136	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.5e-06	0.00134	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.26e-06	0.0013	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.18e-06	0.00129	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.18e-06	0.00129	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.12e-06	0.00128	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.05e-06	0.00127	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.05e-06	0.00127	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.85e-06	0.00124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.72e-06	0.00122	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.61e-06	0.0012	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.5e-06	0.00118	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.49e-06	0.00118	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	7.38e-06	0.00116	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.37e-06	0.00116	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.25e-06	0.00114	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.29e-06	0.000992	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.19e-06	0.000976	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.97e-06	0.000941	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.88e-06	0.000926	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.2e-06	0.00082	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.13e-06	0.000809	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.12e-06	0.000807	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.05e-06	0.000796	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.64e-06	0.00073	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.56e-06	0.000719	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	4.43e-06	0.000698	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	4.36e-06	0.000687	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.57e-06	0.000562	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.51e-06	0.000553	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.07e-06	0.000484	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.02e-06	0.000477	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.11e-06	0.000332	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.07e-06	0.000327	CbGpPWpGaD
